[1]
S. S. Kiani, S. Munir, and L. Ansari, “Ticagrelor-Induced Junctional Bradycardia Following Primary Percutaneous Coronary Intervention: A Clinically Significant and Reversible Adverse Effect ”, Pak. j. Cardio vas. int. (print/Online), vol. 5, no. 2, pp. 74–79, Dec. 2025.